marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Psychemedics Corporation Balance Sheet 2011-2024 | PMD
Annual Balance Sheet Psychemedics Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-3.41 M | -409 K | 1.49 M | -4.65 M | -2.44 M | -4.79 M | -557 K | 3.2 M | 2.64 M | -3.97 M | -3.07 M | -5.56 M | |
Long Term Debt |
- | 305 K | 599 K | 3.44 M | 1.95 M | 1.21 M | 2.42 M | 2.24 M | 4.27 M | 4.85 M | - | - | - |
Long Term Debt Current |
1.05 M | 1.04 M | 984 K | 875 K | 963 K | 416 K | 957 K | 1.14 M | 1.62 M | 1.4 M | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 4.88 M | 2.17 M | 3.66 M | 4.93 M | 7.12 M | 7.64 M | 1.31 M | 815 K | 483 K |
Total Current Liabilities |
4.71 M | 5.72 M | 5.83 M | 3.94 M | 5.84 M | 4.06 M | 4.22 M | 4.5 M | 3.56 M | 3.6 M | 2.96 M | 2.08 M | 2.28 M |
Total Liabilities |
5.65 M | 7.96 M | 9.31 M | 11.5 M | 10.7 M | 6.23 M | 7.89 M | 9.42 M | 10.7 M | 11.2 M | 4.27 M | 2.9 M | 2.77 M |
Deferred Revenue |
- | - | - | - | - | - | 78 K | 125 K | - | - | - | - | - |
Retained Earnings |
-16.8 M | -11.8 M | -9.55 M | -8.61 M | -3.75 M | -1.33 M | -2.11 M | -4.94 M | -8.3 M | -6.57 M | -6.56 M | -7.19 M | -7.01 M |
Total Assets |
12.3 M | 18.7 M | 21.6 M | 24 M | 27.5 M | 25 M | 26.5 M | 25 M | 22.4 M | 24.1 M | 16.5 M | 14.1 M | 13.8 M |
Cash and Cash Equivalents |
1.96 M | 4.75 M | 1.99 M | 2.83 M | 7.28 M | 4.07 M | 8.16 M | 3.94 M | 2.69 M | 3.61 M | 3.97 M | 3.07 M | 5.56 M |
Book Value |
6.67 M | 10.8 M | 12.2 M | 12.5 M | 16.8 M | 18.7 M | 18.6 M | 15.6 M | 11.7 M | 12.8 M | 12.3 M | 11.2 M | 11 M |
Total Shareholders Equity |
6.67 M | 10.8 M | 12.2 M | 12.5 M | 16.8 M | 18.7 M | 18.6 M | 15.6 M | 11.7 M | 12.8 M | 12.3 M | 11.2 M | 11 M |
All numbers in USD currency
Quarterly Balance Sheet Psychemedics Corporation
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
61 K | 623 K | 687 K | 945 K | 77 K | 154 K | 230 K | 305 K | 380 K | 453 K | 526 K | 599 K | 740 K | 3.1 M | 3.27 M | 3.44 M | 3.44 M | 3.44 M | 3.44 M | 1.95 M | 1.95 M | 1.95 M | 1.95 M | 1.21 M | 1.21 M | 1.21 M | 1.21 M | 2.42 M | 2.42 M | 2.42 M | 2.42 M | 2.24 M | 2.24 M | 2.24 M | 2.24 M | 4.27 M | 4.27 M | 4.27 M | 4.27 M | 4.85 M | 4.85 M | 4.85 M | 4.85 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
4.39 M | 4.37 M | 4.87 M | 5.65 M | 6.68 M | 7.26 M | 7.74 M | 7.96 M | 8.76 M | 8.51 M | 8.51 M | 9.31 M | 9.61 M | 11.5 M | 11.6 M | 11.5 M | 11.5 M | 11.5 M | 11.5 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 6.23 M | 6.23 M | 6.23 M | 6.23 M | 7.89 M | 7.89 M | 7.89 M | 7.89 M | 9.42 M | 9.42 M | 9.42 M | 9.42 M | 10.4 M | 10.7 M | 10.7 M | 10.7 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 4.27 M | 4.27 M | 4.27 M | 4.27 M | 2.9 M | 2.9 M | 2.9 M | 2.9 M | 2.77 M | 2.77 M | 2.77 M | 2.77 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 78 K | - | - | - | 125 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 11.4 K | - |
Retained Earnings |
-18.8 M | -18.3 M | -17.5 M | -16.8 M | -15.8 M | -13.7 M | -12.6 M | -11.8 M | -10.7 M | -10.2 M | -9.51 M | -9.55 M | -7.65 M | -8.39 M | -8.52 M | -8.61 M | -8.61 M | -8.61 M | -8.61 M | -3.75 M | -3.75 M | -3.75 M | -3.75 M | -1.33 M | -1.33 M | -1.33 M | -1.33 M | -2.11 M | -2.11 M | -2.11 M | -2.11 M | -4.94 M | -4.94 M | -4.94 M | -4.94 M | -8.3 M | -8.3 M | -8.3 M | -8.3 M | -6.57 M | -6.57 M | -6.57 M | -6.57 M | -6.56 M | -6.56 M | -6.56 M | -6.56 M | -7.19 M | -7.19 M | -7.19 M | -7.19 M | -7.01 M | -7.01 M | -7.01 M | -7.01 M |
Total Assets |
9.84 M | 10.1 M | 11.2 M | 12.3 M | 14.1 M | 16.4 M | 17.9 M | 18.7 M | 20.5 M | 20.4 M | 21 M | 21.6 M | 23.6 M | 24.6 M | 24.4 M | 24 M | 24 M | 24 M | 24 M | 27.5 M | 27.5 M | 27.5 M | 27.5 M | 25 M | 25 M | 25 M | 25 M | 26.5 M | 26.5 M | 26.5 M | 26.5 M | 25 M | 25 M | 25 M | 25 M | 22 M | 22.4 M | 22.4 M | 22.4 M | 24.1 M | 24.1 M | 24.1 M | 24.1 M | 16.5 M | 16.5 M | 16.5 M | 16.5 M | 14.1 M | 14.1 M | 14.1 M | 14.1 M | 13.8 M | 13.8 M | 13.8 M | 13.8 M |
Cash and Cash Equivalents |
1.4 M | 1.43 M | 1.42 M | 1.96 M | 1.37 M | 2.44 M | 4.38 M | 4.75 M | 3.46 M | 1.79 M | 2.13 M | 1.99 M | 1.97 M | 2.65 M | 2.19 M | 2.83 M | 2.83 M | 2.83 M | 2.83 M | 7.28 M | 6.49 M | 7.1 M | 7.28 M | 4.07 M | 4.07 M | 4.07 M | 4.07 M | 8.16 M | 8.16 M | 8.16 M | 8.16 M | 3.94 M | 3.94 M | 3.94 M | 3.94 M | 2.69 M | 2.69 M | 2.69 M | 2.69 M | 3.61 M | 3.61 M | 3.61 M | 3.61 M | 3.97 M | 3.97 M | 3.97 M | 3.97 M | 3.07 M | 3.07 M | 3.07 M | 3.07 M | 5.56 M | 5.56 M | 5.56 M | 5.56 M |
Book Value |
5.45 M | 5.74 M | 6.28 M | 6.67 M | 7.43 M | 9.13 M | 10.2 M | 10.8 M | 11.7 M | 11.9 M | 12.5 M | 12.2 M | 14 M | 13.1 M | 12.8 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 18.7 M | 18.7 M | 18.7 M | 18.7 M | 18.6 M | 18.6 M | 18.6 M | 18.6 M | 15.6 M | 15.6 M | 15.6 M | 15.6 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M | 12.3 M | 12.3 M | 12.3 M | 12.3 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 11 M | 11 M | 11 M | 11 M |
Total Shareholders Equity |
5.45 M | 5.74 M | 6.28 M | 6.67 M | 7.43 M | 9.13 M | 10.2 M | 10.8 M | 11.7 M | 11.9 M | 12.5 M | 12.2 M | 14 M | 13.1 M | 12.8 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 18.7 M | 18.7 M | 18.7 M | 18.7 M | 18.6 M | 18.6 M | 18.6 M | 18.6 M | 15.6 M | 15.6 M | 15.6 M | 15.6 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M | 12.3 M | 12.3 M | 12.3 M | 12.3 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 11 M | 11 M | 11 M | 11 M |
All numbers in USD currency